PharmaVentures, M&A

PharmaVentures acts as the exclusive M&A advisor on the successful sale of Phasefocus to Bruker

Published on 08/07/2025 at 18:07 | prnewswire.co.uk

PharmaVentures Ltd. England United Kingdom United States of America

View original content:https://www.prnewswire.co.uk/news-releases/pharmaventures-acts-as-the-exclusive-ma-advisor-on-the-successful-sale-of-phasefocus-to-bruker-302092131.html

en | boerse | 67948196 |